Insider Transactions in Q3 2023 at Forte Biosciences, Inc. (FBRX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 31
2023
|
David W Gryska |
BUY
Grant, award, or other acquisition
|
Direct |
148,514
+50.0%
|
$148,514
$1.01 P/Share
|
|
Jul 31
2023
|
Donald Allen Williams |
BUY
Grant, award, or other acquisition
|
Direct |
59,405
+50.0%
|
$59,405
$1.01 P/Share
|
|
Jul 31
2023
|
Steven Kornfeld |
BUY
Grant, award, or other acquisition
|
Direct |
99,009
+50.0%
|
$99,009
$1.01 P/Share
|
|
Jul 31
2023
|
Paul A. Wagner |
BUY
Grant, award, or other acquisition
|
Direct |
247,524
+12.87%
|
$247,524
$1.01 P/Share
|
|
Jul 31
2023
|
Antony A Riley CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
148,514
+45.66%
|
$148,514
$1.01 P/Share
|
|
Jul 31
2023
|
Hubert C Chen Officer |
BUY
Grant, award, or other acquisition
|
Direct |
74,257
+46.9%
|
$74,257
$1.01 P/Share
|
|
Jul 01
2023
|
Paul A. Wagner |
SELL
Payment of exercise price or tax liability
|
Direct |
2,453
-0.17%
|
$2,453
$1.04 P/Share
|
|
Jul 01
2023
|
Paul A. Wagner |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+2.14%
|
-
|
|
Jul 01
2023
|
Antony A Riley CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,241
-11.57%
|
$3,241
$1.04 P/Share
|
|
Jul 01
2023
|
Antony A Riley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+25.08%
|
-
|
|
Jul 01
2023
|
Hubert C Chen Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,593
-20.9%
|
$2,593
$1.04 P/Share
|
|
Jul 01
2023
|
Hubert C Chen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+37.68%
|
-
|